OBJECTIVES: To investigate the relationship between ICU-acquired weakness (ICUAW) signatures and sepsis-related mortality using gene expression from the blood within 24 hours of sepsis onset. DESIGN: Observational study using differential gene expression analysis. SETTING: Publicly available gene expression profile GSE54514, single-center medical and surgical ICU. PATIENTS: Patients with primary bacteremia- and respiratory-triggered sepsis including 8 nonsurvivors and 13 survivors who were 18 years old and older and admitted to ICU. MEASUREMENTS AND MAIN RESULTS: Among validated 526 ICUAW gene signatures, differential gene expression analysis controlling for age identified 38 significantly expressed genes between nonsurvivors and survivors. Functional enrichment analysis of differentially expressed ICUAW genes identified impaired cadherin binding, sarcomere formation, and energy metabolism among nonsurvivors. CONCLUSIONS: Our findings demonstrated a biological association between sepsis-related mortality and ICUAW signatures in the early phase of sepsis. Defects in energy metabolism and muscle fiber formation were associated with sepsis-related mortality.
We present BIOCURRENT, a causal inference framework that reconstructs donor-specific pseudotime geometry in transcriptomic data. By modeling gene expression as a function of base-line characteristics, microenvironmental context, and latent pseudotime, BIOCURRENT enables comparison of compressed or expanded progression intervals across transcriptional state transitions. We introduce ΔΔ T , a geometry-based estimator that quantifies differences in pseudotime intervals across conditions, enabling evaluation of changes in pseudotime intervals under hypothetical modulation of microenvironmental programs. Applications to thymic T-cell developmental lineages and to COVID-19 immune dysregulation reveal condition- and donor-specific distortions of progression intervals. Counterfactual simulation links microenvironmental context to changes in specific intracellular state transition intervals. By localizing deviations in pseudotime geometry, BIOCURRENT identifies whether shifts in transcriptomic programs emerge early or later along transcriptomic coordinates and reveals upstream programs associated with these distortions. Such localization supports transcriptional stage-aware mechanistic hypotheses and suggests candidate intervention checkpoints in complex biological systems.
Background/Objectives: Polydimethylsiloxane (PDMS) is a non-invasive and versatile material often used for non-invasive collection of skin-emitted volatile organic compounds (VOCs), with potential applicability in acute and pre-critical care settings. However, most existing PDMS-based methodologies rely on extensive sample preparation and environmental control, limiting their feasibility in time-sensitive clinical contexts. Methods: We conducted a proof-of-concept pilot case-series study in four healthy volunteers to evaluate whether a simplified skin-contact PDMS sampling procedure can capture detectable VOCs and preserve individual-level variation. PDMS strips were applied directly to the skin with minimal preparation, and collected VOCs were analyzed using gas chromatography–mass spectrometry. Donor-associated variability was assessed using Bray–Curtis dissimilarity, and variability in VOC detection was evaluated across body sites. Results: Skin-contact PDMS sampling detected 160 VOCs across four participants. The mean within-donor Bray–Curtis dissimilarity was 0.308, compared with a mean between-donor dissimilarity of 0.347. VOC detection variability differed across body sites, with lower coefficients of variation at the forehead, neck, and wrist than at the ankle. Conclusions: Under simplified sampling conditions, skin-contact PDMS captured individual-associated VOC profiles with lower within-donor variability than between-donor variability. These findings support the feasibility of PDMS-based skin VOC sampling in minimally controlled settings. Further validation in larger and clinically relevant cohorts is warranted to assess the utility of PDMS-sampled skin VOCs as potential biomarkers for early disease detection.
Background: Polydimethylsiloxane (PDMS) is a non-invasive and versatile material often used for non-invasive collection of skin-emitted volatile organic compounds (VOCs), with potential applicability in acute and pre-critical care settings. However, most existing PDMS-based methodologies rely on extensive sample preparation and environmental control, limiting their feasibility in time-sensitive clinical contexts. Methods: We conducted a proof-of-concept pilot study in four healthy volunteers to evaluate whether a simplified skin-contact PDMS sampling procedure can capture detectable VOCs and preserve individual-level variation. PDMS strips were applied directly to the skin with minimal preparation, and collected VOCs were analyzed using gas chromatography-mass spectrometry. Donor-associated variability was assessed using Bray-Curtis dissimilarity, and variability in VOC detection was evaluated across body sites. Results: Skin-contact PDMS sampling detected 160 VOCs across four participants. The mean within-donor Bray-Curtis dissimilarity was 0.308, compared with a mean between-donor dissimilarity of 0.347. Preliminary permutation testing showed distinguishable donor profiles (p-value = 0.004). VOC detection variability differed across body sites, with lower coefficients of variation at the forehead, neck, and wrist than at the ankle. Conclusions: Under simplified sampling conditions, skin-contact PDMS captured individual-associated VOC profiles with lower within-donor variability than between-donor variability. These findings support the feasibility of PDMS-based skin VOC sampling in minimally controlled settings. Further validation in larger and clinically relevant cohorts is warranted to assess the utility of PDMS-sampled skin VOCs as potential biomarkers for early disease detection.